Correlation Between NYSE Composite and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and X4 Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and X4 Pharmaceuticals.
Diversification Opportunities for NYSE Composite and X4 Pharmaceuticals
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and XFOR is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and X4 Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.09 times more return on investment than X4 Pharmaceuticals. However, NYSE Composite is 10.83 times less risky than X4 Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 1,930,323 in NYSE Composite on May 5, 2025 and sell it today you would earn a total of 96,446 from holding NYSE Composite or generate 5.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. X4 Pharmaceuticals
Performance |
Timeline |
NYSE Composite and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
X4 Pharmaceuticals
Pair trading matchups for X4 Pharmaceuticals
Pair Trading with NYSE Composite and X4 Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.NYSE Composite vs. Lincoln Electric Holdings | NYSE Composite vs. Utah Medical Products | NYSE Composite vs. Haemonetics | NYSE Composite vs. Nextplat Corp |
X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |